Repository logo
Andean Publishing ↗
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Autor "Real, Juan Pablo"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item type: Item ,
    Mathematical and Pharmacokinetic Approaches for the Design of New 3D Printing Inks Using Ricobendazole.
    (2022) Barberis, María Eugenia; Palma, Santiago Daniel; Gonzo, Elio Emilio; Bermúdez, José María; Lorier, Marianela; Ibarra, Manuel; Real, Juan Pablo
    PURPOSE: 3D printing (3DP) makes it possible to obtain systems that are not achievable with current conventional methods, one of them, sustained release floating systems. Floating systems using ricobendazole (RBZ) as a model drug and a combination of polymers were designed and obtained by melt solidification printing technique (MESO-PP). METHODS: Four different MESO-PP inks were formulated based on combinations of the polymers Gelucire 43/01 and Gelucire 50/13 in different ratios. For each of the formulated inks, physicochemical characterization was performed by thermal analysis (thermogravimetric analysis [TGA] and differential scanning calorimetry [DSC]), fourier transform infrared spectrophotometer (FTIR) and X-ray diffraction (XRD). Pharmaceutical characterization was performed by in vitro assays to determine pharmaceutically relevant parameters. These parameters were calculated by applying mathematical models developed to evaluate in vitro drug release profiles. On the other hand, a physiologically based pharmacokinetic (PBPK) model was developed to predict the in vivo performance of RBZ loaded in the different inks by determining the Cmax, and the AUC0-∞. RESULTS: By increasing the proportion of Gelucire 50/13 co-surfactant in the mixtures (the proportion in Ink 1 was 33%, while the proportion in Ink 4 was 80%), the dissolution capacity of RBZ increases substantially, decreasing flotation times. CONCLUSION: MESO-PP produced ink 1 (50% Gelucire 43/01, 25% Gelucire 50/13 and 25% RBZ), which has a zero-order release (RR = 0.180%/min) and the longest flotation time (545 ± 23 min), and in turn would produce a significant increase in oral absorption of the drug, with an AUC0-∞ 2.16-fold higher than that obtained in animals treated with RBZ loaded in conventional tablets.
  • Loading...
    Thumbnail Image
    Item type: Item ,
    Modeling and evaluation of ivermectin release kinetics from 3D-printed tablets.
    (2024) Briones Nieva, Cintia Alejandra; Real, Juan Pablo; Campos, Santiago Nicolás; Romero, Analía Irma; Villegas, Mercedes; Gonzo, Elio Emilio; Bermúdez, José María; Palma, Santiago Daniel; Cid, Alicia Graciela
    Aim: This study focused on evaluating the influence of geometric dimensions on the drug release kinetics of 3D-printed tablets.Materials & methods: An ink based on Gelucire 50/13 was prepared to print ivermectin-loaded tablets. The ink was characterized physicochemically and tablet dissolution tests were carried out.Results: The results confirmed the suitability of the ink for 3D printing at a temperature >46°C. Changes in the crystallinity of ivermectin were observed without chemical interactions with the polymer. 3D printed tablets with varied proportional sizes showed dual behavior in their release profiles, while tablets with only thickness reduction exhibited zero-order kinetics.Conclusion: These findings highlight the versatility of 3D printing to create systems with specific and customized release profiles.

Andean Library © 2026 · Andean Publishing

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback